drugset / Trial / NCT01373476
Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy
Phase 2
Completed
240 enrolled
Chengdu University of Traditional Chinese Medicine
Chongqing Taiji Group of Fuling pharmaceutical Co., LTD · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Objectives of study: To preliminarily evaluate the efficacy and safety of Qideng Mingmu Capsule in the treatment of patients with diabetic retinopathy (deficiency of Qi-Yin syndrome, blood stasis syndrome), to discuss the appropriate dose and period of treatment.
Timeline
- Start
- 2011-03
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Qideng Mingmu capsule | Unknown | 1 unknown | Oral |
| Subject | Qideng Mingmu capsule | Unknown | 2 unknown | Oral |
| Subject | Qideng Mingmu capsule | Unknown | 4 unknown | Oral |